[PDF][PDF] 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea

G Cappon, M Vettoretti, G Sparacino… - Diabetes & …, 2019 - synapse.koreamed.org
By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …

[HTML][HTML] Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: a position statement of the Fatty Liver Research Group of the Korean Diabetes …

BW Lee, Y Lee, CY Park, EJ Rhee… - Diabetes & …, 2020 - synapse.koreamed.org
This clinical practice position statement, a product of the Fatty Liver Research Group of the
Korean Diabetes Association, proposes recommendations for the diagnosis, progression …

[PDF][PDF] Past and current status of adult type 2 diabetes mellitus management in Korea: a National Health Insurance Service database analysis

SH Ko, K Han, Y Lee, J Noh, CY Park… - Diabetes & …, 2018 - synapse.koreamed.org
Korea's National Healthcare Program, the National Health Insurance Service (NHIS), a
government-affiliated agency under the Korean Ministry of Health and Welfare, covers the …

Efficacy and safety of mulberry twig alkaloids tablet for the treatment of type 2 diabetes: A multicenter, randomized, double-blind, double-dummy, and parallel …

L Qu, X Liang, G Tian, G Zhang, Q Wu, X Huang… - Diabetes …, 2021 - Am Diabetes Assoc
OBJECTIVE This study aimed to evaluate the efficacy and safety of mulberry twig alkaloids
(Sangzhi alkaloids [SZ-A]) in the treatment of type 2 diabetes (T2D). RESEARCH DESIGN …

Medical big data is not yet available: why we need realism rather than exaggeration

HS Kim, DJ Kim, KH Yoon - Endocrinology and Metabolism, 2019 - synapse.koreamed.org
Most people are now familiar with the concepts of big data, deep learning, machine learning,
and artificial intelligence (AI) and have a vague expectation that AI using medical big data …

Effect of sodium‐glucose cotransporter 2 inhibitor, empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes

JW Kim, YJ Lee, YH You, MK Moon… - Journal of cellular …, 2019 - Wiley Online Library
Objective We investigated the effects of sodium‐glucose cotransporter 2 inhibitor,
empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal …

Nationwide trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors

M Lee, J Sun, M Han, Y Cho, JY Lee, CM Nam… - Diabetes …, 2019 - Am Diabetes Assoc
OBJECTIVE Dipeptidyl peptidase 4 inhibitors (DPP-4i) are useful incretin-based
antidiabetes drugs. However, there is a concern that DPP-4i may adversely impact the …

Development and validation of a risk prediction model for severe hypoglycemia in adult patients with type 2 diabetes: a nationwide population-based cohort study

K Han, JS Yun, YM Park, YB Ahn, JH Cho… - Clinical …, 2018 - Taylor & Francis
Purpose There is a scarcity of long-term prediction models for severe hypoglycemia (SH) in
subjects with type 2 diabetes mellitus (T2DM). In this study, a model was developed and …

[HTML][HTML] Effect of voluntary participation on mobile health care in diabetes management: randomized controlled open-label trial

SH Yoo, KP Min, CY Park - JMIR mHealth and uHealth, 2020 - mhealth.jmir.org
Background: The role of mobile health care (mHealth) in glycemic control has been
investigated, but its impact on self-management skills and its psychological aspects have not …

Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: a …

KA Han, S Chon, CH Chung, S Lim… - Diabetes, Obesity …, 2018 - Wiley Online Library
Aim To evaluate the efficacy and safety of ipragliflozin vs placebo as add‐on therapy to
metformin and sitagliptin in Korean patients with type 2 diabetes mellitus (T2DM). Methods …